We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Memorial Sloan Kettering Cancer Center, Quest Diagnostics Partner

News   Jun 02, 2014

 
Memorial Sloan Kettering Cancer Center, Quest Diagnostics Partner
 
 
Advertisement
 

RELATED ARTICLES

On-the-Spot Coronavirus Test Within Spitting Distance

News

Mass testing that is fast, non-invasive and able to identify cases before people show symptoms holds the key to boosting COVID-19 detection, improving contact tracing and managing disease outbreaks.

READ MORE

A Potential Target for Chemo-Resistant Cancer Cells

News

As researchers and medical professionals work to develop new treatments for cancer, they face a variety of challenges. One is intratumor heterogeneity -- the presence of multiple kinds of cancer cells within the same tumor. Often, these "mosaic" tumors include cells, such as polyploidal giant cancer cells, that have evolved to become aggressive and resistant to chemotherapy and radiation.

READ MORE

A Potential Diagnostic Test and Molecular Target for Machado-Joseph Disease

News

Researchers have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3), a disease that currently has no cure. The team has also have uncovered the role of a gene target linked to the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE